Migraine Clinical Trials in Nashville, Tennessee

5 studies are recruiting for migraine in Nashville, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

   This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerab…

   Stage

   Phase 4

   Ages

   18 to 70

   Site

   Vanderbilt Medical Center, Nashville, Tennessee

   Locations

   36 in total

   Run by

   Mayo Clinic

   See if you can join NCT06972056 on ClinicalTrials.gov

2. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

   Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   Access Clinical Trials, Inc. /ID# 228002, Nashville, Tennessee

   Locations

   129 in total

   Run by

   AbbVie

   See if you can join NCT05125302 on ClinicalTrials.gov

3. Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

   This study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the study. Neither partic…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   Clinical Research Associates, Inc., Nashville, Tennessee

   Locations

   6 in total

   Run by

   Aspeya, Inc.

   See if you can join NCT07646613 on ClinicalTrials.gov

4. Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

   The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to <18 years with episodic migraine.

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee

   Locations

   93 in total

   Run by

   Pfizer

   See if you can join NCT05156398 on ClinicalTrials.gov

5. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

   This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Access Clinical Trials, Inc, Nashville, Tennessee

   Locations

   113 in total

   Run by

   Kallyope Inc.

   See if you can join NCT07645924 on ClinicalTrials.gov